ERBB2 and neoplasm: This review aims to provide a comprehensive overview of the impact of HER2 on the TME in EGA, summarize the mechanisms by which HER2 signalling can shape tumour progression and immune evasion, and explore the implications of these findings for HER2-directed treatments.